ARCTIC PHARMA AS

0372 OSLO

Finances

Share Ownership

Return on Equity

−34,22 %

Current Ratio

1,55

Debt-to-Equity Ratio

0,17

Key figures (NOK)	2022	2021	2020	2019
Revenue	5 483 000	7 287 000	4 663 000	353 000
Net Income	−1 747 000	−2 185 000	−1 905 000	9 000
Total Assets	7 395 000	9 240 000	6 488 000	3 559 000
Total Equity	5 105 000	5 752 000	3 938 000	2 843 000

Income (NOK)	2022	2021	2020	2019
Revenue	5 483 000	7 287 000	4 663 000	353 000
Expenditure	7 212 000	9 474 000	6 549 000	331 000
Operating Profit	−1 730 000	−2 187 000	−1 886 000	21 000
Financial Income	43 000	68 000	9 000	−9 000
Financial Costs	60 000	67 000	28 000	4 000
Financial Balance	−17 000	1 000	−19 000	−13 000
Earnings Before Tax	−1 747 000	−2 185 000	−1 905 000	9 000
Tax	0	0	0	0
Net Income	−1 747 000	−2 185 000	−1 905 000	9 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	5 211 000	5 644 000	3 929 000	2 476 000
Total Current Assets	2 183 000	3 596 000	2 559 000	1 084 000
Total Assets	7 395 000	9 240 000	6 488 000	3 559 000
Total Retained Equity	0	0	0	0
Total Equity	5 105 000	5 752 000	3 938 000	2 843 000
Total Long-Term Debt	880 000	1 002 000	764 000	492 000
Total Current Debt	1 410 000	2 486 000	1 786 000	224 000
Total Equity and Debt	7 395 000	9 240 000	6 488 000	3 559 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	618 000	57 000	63 000	198 000
Other Income	4 865 000	7 230 000	4 600 000	155 000
Revenue	5 483 000	7 287 000	4 663 000	353 000
Cost of Goods Sold	18 000	0	53 000	2 000
Salary Costs	231 000	119 000	1 044 000	−468 000
Depreciation	2 072 000	1 750 000	1 056 000	281 000
Impairment	0	0	0	0
Expenditure	7 212 000	9 474 000	6 549 000	331 000
Operating Profit	−1 730 000	−2 187 000	−1 886 000	21 000
Financial Income	43 000	68 000	9 000	−9 000
Financial Costs	60 000	67 000	28 000	4 000
Financial Balance	−17 000	1 000	−19 000	−13 000
Dividends	0	0	0	0
Net Income	−1 747 000	−2 185 000	−1 905 000	9 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	5 204 000	5 631 000	3 921 000	2 461 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	7 000	13 000	8 000	15 000
Total Tangible Assets	7 000	13 000	8 000	15 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	5 211 000	5 644 000	3 929 000	2 476 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	817 000	867 000	349 000	436 000
Total Current Assets	2 183 000	3 596 000	2 559 000	1 084 000
Total Assets	7 395 000	9 240 000	6 488 000	3 559 000
Total Equity	5 105 000	5 752 000	3 938 000	2 843 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	880 000	1 002 000	764 000	492 000
Creditors	614 000	2 287 000	1 006 000	201 000
Unpaid Taxes	178 000	37 000	225 000	6 000
Dividends	0	0	0	0
Other Current Debt	618 000	162 000	555 000	17 000
Total Current Debt	1 410 000	2 486 000	1 786 000	224 000
Total Equity and Debt	7 395 000	9 240 000	6 488 000	3 559 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−34,22 %	−37,99 %	−48,37 %	0,32 %
Debt-to-Equity Ratio	0,17	0,17	0,19	0,17
Operating Profit Margin	−31,55 %	−30,01 %	−40,45 %	5,95 %
Current Ratio	1,55	1,45	1,43	4,84
Quick Ratio	1,55	1,45	1,43	4,84
Equity Ratio	0,69	0,62	0,61	0,8
Gross Profit Margin	99,67 %	100 %	98,86 %	99,43 %